High blood sugar and the death rate in critically ill people suffering from covid-19
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/02/040067
- Lead Sponsor
- orth Eastern Indira Gandhi Regional Institute of Health and Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient who had a covid-19 disease
- Patients more than 18 years.
- Patients of either sex.
- Patients who are admitted in the covid-19 intensive care unit.
Exclusion Criteria
- Patients who is a known case of diabetes mellitus
- Patients with pre-existing cardiac, liver, kidney diseases
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - To assess the association between the random blood sugar level and mortality in critically ill covid-19 patients. <br/ ><br> <br/ ><br>Timepoint: - To assess the association between the baseline random blood sugar level of covid patients at the time of admission to covid ICU and mortality. <br/ ><br> <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method To observe any other complications occurring in critically ill covid-19 patients with hyperglycemia.Timepoint: To observe any other complications occurring in critically ill covid-19 patients with hyperglycemia during their stay in covid icu.